SCHEMBL4097267

SCHEMBL4097267

CCCCCCCC/C=C\CCCCCCCCCCCC(=O)Oc1cc(C=Cc2ccc(O)cc2)cc(OC(=O)CCCCCCCCCCC/C=C\CCCCCCCC)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSMB11 A5LHX3 3/20 0.50
PSMA7 O14818 3/20 0.50
PSMB1 P20618 3/20 0.50
PSMA1 P25786 3/20 0.50
PSMA2 P25787 3/20 0.50
PSMA3 P25788 3/20 0.50
PSMA4 P25789 3/20 0.50
PSMB8 P28062 3/20 0.50
PSMB9 P28065 3/20 0.50
PSMA5 P28066 3/20 0.50
PSMB4 P28070 3/20 0.50
PSMB6 P28072 3/20 0.50
PSMB5 P28074 3/20 0.50
PSMB10 P40306 3/20 0.50
PSMB3 P49720 3/20 0.50
PSMB2 P49721 3/20 0.50
PSMA6 P60900 3/20 0.50
PSMA8 Q8TAA3 3/20 0.50
PSMB7 Q99436 3/20 0.50
ELANE P08246 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2514397 1.00 PSMB11 (0.50) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL2518028 0.98 PSMB11 (0.48) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL2519715 0.97 PSMB11 (0.49) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL4092190 0.97 PSMB11 (0.49) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL2513369 0.94 PSMB11 (0.47) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL4096611 0.94 MAPT (0.51) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL4099548 0.94 TTR (0.50) MEN1MAPTKMT2AGAAMAPK1
SCHEMBL4101923 0.94 TTR (0.50) MEN1MAPTKMT2AGAAMAPK1
SCHEMBL2515023 0.94 TTR (0.50) MEN1MAPTKMT2AGAAMAPK1
SCHEMBL2521977 0.94 TTR (0.50) MEN1MAPTKMT2AGAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9295621-B2 Emulsion cosmetic compositions containing resveratrol derivatives and silicone surfactant ELC MANAGEMENT LLC (US) 2016-03-29 US disclosed
US-20090035240-A1 Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent ELC MANAGEMENT LLC 2009-02-05 US disclosed
US-20090035237-A1 Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant ELC MANAGEMENT LLC 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090035237-A1 Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant SMURF1, CUTA, SMURF2 PSMB11 1301/4885PSMA7 1207/4885PSMB1 1230/4885
US-20090035240-A1 Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent SMARCC1, RARG, RARA PSMB11 3729/4885PSMA7 3567/4885PSMB1 3457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.